1. Patients with laboratory confirmation of infection with SARS-CoV-2 by positive RT-PCR. <br/ >2. Patients with moderate COVID-19 (According to Clinical Management Protocol: COVID 19, Govt. of India). <br/ >-Patients with presence of clinical features of dyspnea and or hypoxia, fever, cough, including SpO2 <94% (range 90-94%) on room air <br/ >-Respiratory Rate â?¥24 per minute <br/ >-Pneumonia with no signs of severe disease <br/ >3. Symptomatic adult male or non-pregnant female (â?¥18 years) <br/ >4. Voluntarily participating in the clinical study and patients or legal representative willing to sign informed consent.

1. Patients with laboratory confirmation of infection with SARS-CoV-2 by positive RT-PCR. <br/ >2. Patients with moderate COVID-19 (According to Clinical Management Protocol: COVID 19, Govt. of India). <br/ >-Patients with presence of clinical features of dyspnea and or hypoxia, fever, cough, including SpO2 <94% (range 90-94%) on room air <br/ >-Respiratory Rate â?¥24 per minute <br/ >-Pneumonia with no signs of severe disease <br/ >3. Symptomatic adult male or non-pregnant female (â?¥18 years) <br/ >4. Voluntarily participating in the clinical study and patients or legal representative willing to sign informed consent.

1. Patients with laboratory confirmation of infection with SARS-CoV-2 by positive RT-PCR. <br/ >2. Patients with moderate COVID-19 (According to Clinical Management Protocol: COVID 19, Govt. of India). <br/ >-Patients with presence of clinical features of dyspnea and or hypoxia, fever, cough, including SpO2 <94% (range 90-94%) on room air <br/ >-Respiratory Rate â?¥24 per minute <br/ >-Pneumonia with no signs of severe disease <br/ >3. Symptomatic adult male or non-pregnant female (â?¥18 years) <br/ >4. Voluntarily participating in the clinical study and patients or legal representative willing to sign informed consent.

1. Patients with laboratory confirmation of infection with SARS-CoV-2 by positive RT-PCR. <br/ >2. Patients with moderate COVID-19 (According to Clinical Management Protocol: COVID 19, Govt. of India). <br/ >-Patients with presence of clinical features of dyspnea and or hypoxia, fever, cough, including SpO2 <94% (range 90-94%) on room air <br/ >-Respiratory Rate â?¥24 per minute <br/ >-Pneumonia with no signs of severe disease <br/ >3. Symptomatic adult male or non-pregnant female (â?¥18 years) <br/ >4. Voluntarily participating in the clinical study and patients or legal representative willing to sign informed consent.